143 related articles for article (PubMed ID: 7908664)
21. Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BV
Semin Oncol; 1996 Feb; 23(1 Suppl 1):13-8. PubMed ID: 8629030
[TBL] [Abstract][Full Text] [Related]
22. Single-agent paclitaxel for the treatment of breast cancer: an overview.
Hortobagyi GN; Holmes FA
Semin Oncol; 1996 Feb; 23(1 Suppl 1):4-9. PubMed ID: 8629036
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel and anthracycline combination chemotherapy for metastatic breast cancer.
Kaufman PA
Semin Oncol; 1999 Jun; 26(3 Suppl 8):39-46. PubMed ID: 10403473
[TBL] [Abstract][Full Text] [Related]
24. A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.
Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-5-S17-9. PubMed ID: 9374084
[TBL] [Abstract][Full Text] [Related]
25. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
Bunn PA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
Burstein HJ; Bellon JR; Galper S; Lu HM; Kuter I; Taghian AG; Wong J; Gelman R; Bunnell CA; Parker LM; Garber JE; Winer EP; Harris JR; Powell SN
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):496-504. PubMed ID: 16243442
[TBL] [Abstract][Full Text] [Related]
27. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
[TBL] [Abstract][Full Text] [Related]
28. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.
Forastiere AA
Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
30. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
Hudis CA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
[TBL] [Abstract][Full Text] [Related]
31. The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Hortobagyi GN; Holmes FA; Ibrahim N; Champlin R; Buzdar AU
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S30-3. PubMed ID: 9071338
[TBL] [Abstract][Full Text] [Related]
32. Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer.
Cheson BD; Abrams JS; Arbuck SG; Phillips PH
Oncology (Williston Park); 1994 Jan; 8(1):72-3, 76-7. PubMed ID: 7907222
[No Abstract] [Full Text] [Related]
33. [A case of effective paclitaxel therapy for adriamycin resistant metastatic breast cancer with brain metastases].
Kokufu I; Tanei T; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2002 Apr; 29(4):585-8. PubMed ID: 11977543
[TBL] [Abstract][Full Text] [Related]
34. Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.
Buzdar AU; Hortobagyi GN; Asmar L; Theriault RL; Rahman Z; McNeese M; Singletary S; Ames F
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-31-S17-34. PubMed ID: 9374089
[TBL] [Abstract][Full Text] [Related]
35. Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer.
Cohen PR
J Drugs Dermatol; 2009 Jan; 8(1):61-4. PubMed ID: 19180897
[TBL] [Abstract][Full Text] [Related]
36. Single-agent paclitaxel at first relapse following adjuvant chemotherapy for breast cancer.
Davidson NG
Semin Oncol; 1995 Dec; 22(6 Suppl 14):2-6. PubMed ID: 8553079
[TBL] [Abstract][Full Text] [Related]
37. Preliminary report concomitant irradiation and paclitaxel as radiosensitizer to increase the operability of unresectable locally advanced breast cancer.
Gondhowiardjo S; Poetiray ED; Tjarta A; Djoerban Z; Reksodipoetro AH
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():461-8. PubMed ID: 10895196
[No Abstract] [Full Text] [Related]
38. Taxol plus radiation for head and neck cancer.
Rosenthal DI; Carbone DP
J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
[TBL] [Abstract][Full Text] [Related]
39. Future developments for paclitaxel in the treatment of breast cancer.
Bonadonna G
Semin Oncol; 1996 Feb; 23(1 Suppl 1):65-8. PubMed ID: 8629041
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.
Rincon M; Broadwater G; Harris L; Crocker A; Weaver D; Dressler L; Berry D; Sutton L; Michaelson R; Messino M; Kirshner J; Fleming G; Winer E; Hudis C; Appel S; Norton L; Muss H;
Breast Cancer Res Treat; 2006 Dec; 100(3):301-8. PubMed ID: 16773437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]